Table 2.
Median Values for Polysomnographic, ESS, and SF-36 Variables Comparing the No-SDB and SDB Partners in Group 2
| NoSDB-SDB Group |
P-value* | ||||
|---|---|---|---|---|---|
| Partner A |
Partner B |
||||
| No-SDB Partner | Min-Max | SDB partner | Min-Max | ||
| N | 42 | 42 | |||
| Age (years) | 63 | 47–74 | 66 | 48–77 | <0.0001 |
| BMI | 26 | 22–34 | 29 | 15–42 | 0.0003 |
| RDI 4% | 1.8 | 0–4.9 | 17.9 | 10–68 | <0.0001 |
| Sleep onset latency | 14 | 0–53 | 16 | 1–69 | 0.29 |
| Total sleep time | 400 | 333–456 | 365 | 260–456 | 0.25 |
| Sleep efficiency | 82 | 57–95 | 82 | 57–95 | 0.24 |
| Stage 1 % | 4 | 1–10 | 5 | 1–17 | 0.46 |
| Stage 2 % | 55 | 30–71 | 64 | 35–86 | 0.0001 |
| Stage 3 and 4 % | 21 | 5–47 | 11 | 0–42 | 0.0005 |
| REM% | 20.3 | 8–35 | 20 | 5–35 | 0.22 |
| Arousal index | 13.8 | 5–27 | 20 | 5–60 | <0.0001 |
| Habitual SOL (min) | 15 | 4–120 | 15 | 2–90 | 0.61 |
| Habitual TST (min) | 420 | 300–600 | 450 | 300–540 | 0.94 |
| ESS | 6 | 0–15 | 8 | 2–19 | 0.09 |
| Physical functioning | 50 | 28–50 | 50 | 6–50 | 0.27 |
| Bodily pain | 84 | 0–100 | 74 | 22–100 | 0.57 |
| General health | 82 | 20–100 | 77 | 30–100 | 0.90 |
| Vitality | 73 | 45–90 | 75 | 20–90 | 0.61 |
| Social functioning | 100 | 25–100 | 100 | 50–100 | 0.50 |
| Role-emotional | 100 | 0–100 | 100 | 0–100 | 0.75 |
| Mental health | 84 | 32–100 | 84 | 68–100 | 0.68 |
*
P-value for Wilcoxon matched-pairs signed-ranks test. ESS (Epworth Sleepiness Scale).